Investigation into the efficacy and safety profile of oral small-molecule GLP-1 receptor agonists in type 2 diabetes and obesity: a systematic review and meta-analysis - Top-Institutions - MDSpire

Investigation into the efficacy and safety profile of oral small-molecule GLP-1 receptor agonists in type 2 diabetes and obesity: a systematic review and meta-analysis

  • By

  • Li Li

  • Dianpeng Shui

  • Xiong Zhang

  • Bing Tan

  • Yan Deng

  • July 7, 2026

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    NewYork-Presbyterian Hospital–Weill Cornell Medicine
    NewYork-Presbyterian Hospital–Weill Cornell Medicine

    New York, New York

    Key Differentiators

    • Endocrinology
    • Obesity Medicine

  • #2

    UTHealth Houston
    UTHealth Houston

    Houston, Texas

    Key Differentiators

    • Endocrinology
    • Obesity Medicine

  • #3

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, Ohio

    Key Differentiators

    • Endocrinology

Original Source(s)

Investigation into the efficacy and safety profile of oral small-molecule GLP-1 receptor agonists in type 2 diabetes and obesity: a systematic review and meta-analysis

  • by Li Li, Dianpeng Shui, Xiong Zhang, Bing Tan, Yan Deng

  • July 7, 2026

Related Content

Comparative analysis of glucagon-like peptide-1 receptor agonists, metformin, and inositol in improving anthropometric and metabolic outcomes in women with polycystic ovary syndrome: a network meta-analysis

Medical Oddities: Could GLP-1s Curb Violence?

Five studies, one question: are we overlooking hidden drivers of health?

Outcomes of Metabolic and Bariatric Surgery Among Adolescents and Young Adults in Southern Louisiana